Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




American Society of Health-System Pharmacists 2007 Midyear Clinical Meeting
Link ID 3879
Title American Society of Health-System Pharmacists 2007 Midyear Clinical Meeting
Url http://www.medscape.com/viewprogram/8912?src=rss
Description Read clinically focused news coverage of key developments from the meeting. Medscape Pharmacists
Category Articles > Pharmacists
Keywords
Date Mar 8, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Sorafenib Active Against Hormone-Refractory Prostate Cancer
  Sorafenib, an agent with both antiangiogenic and antiproliferative activity, may represent a useful treatment for progressive hormone-refractory prostate cancer, new research suggests. Reuters Health Information
Category:   Articles > Pharmacists


2. Newer Antipsychotics Ineffective for Psychosis, Aggression in Alzheimer Disease
  Second-generation antipsychotics (SGAs) are no better than placebo from a cost-benefit viewpoint for treating psychosis and aggression in Alzheimer disease patients, according to a report in the November issue of the Archives of General Psychiatry. Reuters Health Information
Category:   Articles > Pharmacists


3. Montelukast Associated With Churg-Strauss Syndrome but Not the Cause
  Although use of the leukotriene receptor antagonist montelukast is associated with a significant risk of Churg-Strauss syndrome (CSS), it is likely "a proxy measure for gradually worsening asthma at an individual level and for the important increase in montelukast exposure in general," researchers conclude in a study published in the August issue of Thorax. Reuters Health Information
Category:   Articles > Pharmacists


4. Beta-Blocker Therapy Important in Patients Hospitalized With Heart Failure
  Continuation of beta-blocker therapy among patients hospitalized for decompensated heart failure is associated with markedly better outcomes compared to heart failure patients in whom beta-blocker therapy is stopped or never started, according to a study published July 15 in the Journal of the American College of Cardiology. Reuters Health Information
Category:   Articles > Pharmacists


5. Weight-Loss Drug Rimonabant Increases Risk for Adverse Psychiatric Effects
  A meta-analysis of 4 randomized trials of the weight-loss drug rimonabant concurs with Food and Drug Administration findings of an increased risk for adverse psychiatric effects. Medscape Medical News
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS